NCT06931743

Brief Summary

To evaluate the efficacy and safety of the wrist and ankle electrical stimulation analgesia therapy device in the management of analgesia after thyroidectomy by conducting clinical studies to collect data. It will also be combined with the Internet of Things technology to develop artificial intelligence equipment or applications to achieve remote monitoring and intelligent alarm, and improve the timeliness and initiative of pain management after thyroidectomy. In the future, we will further carry out a series of research work to explore the possible analgesic mechanisms through molecular biology and neurophysiology.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
668

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Apr 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 17, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 17, 2025

Completed
13 days until next milestone

Study Start

First participant enrolled

April 30, 2025

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

April 17, 2025

Status Verified

April 1, 2025

Enrollment Period

8 months

First QC Date

March 17, 2025

Last Update Submit

April 9, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Pain VAS score

    VAS (Visual Analogue Scale) scoring, namely visual analogue scoring, usually employs a straight line or ruler 10 centimeters long, with0 representing the "no pain end" and 10 representing the "most intense pain". The patient marks on the straight line according to the level of pain he or she, to indicate the intensity of pain and the degree of unpleasant psychological experience. The higher the VAS score, the more painful it is. 0 points: no pain; -3 points: mild pain; 4-6 points: moderate pain; 7-9 severe pain; 10 points: unbearable pain, namely severe pain

    Evaluation time: 1) the subject returned to the ward after surgery; 2) immediately after electrical stimulation; 3) Postoperative 3 hours、Postoperative 9 hours、Postoperative 15 hours、Postoperative 24 hours

  • Pain-related measures

    Pain-related indicators: Comparison of blood-related indicators between the control group and the intervention group of patients before and 3 hours after surgery, such as C-reactive protein (CRP), erythrocyte sedimentation rate (ESR), and interleukin (ILs).

    Preoperative and Postoperative 3 hours

Secondary Outcomes (2)

  • PONV classification

    Postoperative 3 hours、Postoperative 9 hours、Postoperative 15 hours、Postoperative 24 hours

  • 40-item Quality of Recovery (QoR-40) score

    Postoperative 24 hours

Study Arms (2)

Placebo group

PLACEBO COMPARATOR
Device: CMNS6-1 Electronic Acupuncture Therapeutic Apparatus

CMNS6-1 Electronic Acupuncture Therapeutic Apparatus

EXPERIMENTAL

CMNS6-1 Electronic Acupuncture Therapeutic Apparatus

Device: CMNS6-1 Electronic Acupuncture Therapeutic Apparatus

Interventions

1. The time selection of acupoint treatment is to return to the ward immediately,2 and 4 hours after surgery; 2. Time of each stimulation: 30min; 3. Acupoint extraction: According to the theory of wrist and ankle acupuncture and the location of pain, the upper 1 area (the ulnar margin on the little finger side and the depression of the flexor carpi ulnaris tendon) and the upper 2 area (between the palmaris longus tendon and the flexor carpi radialis on both sides) on the affected side (bilateral for total thyroidectomy) were selected as the intervention site, and the upper and lower parallel electrodes were placed in each area, and a total of 4 electrodes (8 electrodes on both sides) were placed. 4. The parameter setting of the equipment: the frequency is set to 2Hz, the pulse width is set to 500μs, continuous wave is used, and the current intensity is the maximum tolerance of the subject's small pain threshold for 30min.

Also known as: Experimental Arm
CMNS6-1 Electronic Acupuncture Therapeutic Apparatus

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Be over 18 years of age;
  • The operation time is less than 4 hours;
  • Postoperative VAS pain score ≥3 points ;
  • Clear consciousness, able to answer questions accurately, free speech, no hearing impairment;
  • Informed consent

You may not qualify if:

  • Neck or thyroid surgery within the past ten years;
  • Menstruating, pregnant and lactating females;Those who are not satisfied with blood glucose control;
  • Skin injury or allergy; skin ulceration;
  • Past history of psychiatric disorder that met the diagnostic criteria of Diagnostic and Manual of Mental Disorders, DSM-IV;
  • Upper respiratory tract infection within 2 weeks before surgery;
  • History of implantation of pace or defibrillator;
  • Allergic to gel or intolerant to electrical stimulation;
  • History of chronic pain, pain VAS score 1 at the examination;
  • Use of sedative analgesic drugs for a long time or within 24 hours;
  • Particip in other clinical trials in the past 4 weeks.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Wrist and Ankle Electrical Stimulation Analgesia Therapy Device

Shanghai, Yangpu District, 200000, China

Location

MeSH Terms

Conditions

Thyroid Neoplasms

Condition Hierarchy (Ancestors)

Endocrine Gland NeoplasmsNeoplasms by SiteNeoplasmsHead and Neck NeoplasmsEndocrine System DiseasesThyroid Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 17, 2025

First Posted

April 17, 2025

Study Start

April 30, 2025

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

April 17, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations